Beractant
Therapeutic Group
Lung SurfactantsIndication Dosage
Prophylaxis & Treatment Of Neonatal Respiratory Distress Syndrome (rds) (hyaline Membrane Disease) In Premature Infants:
For Intratracheal Administration Only, Ee Literature
Content
- Inj: Per ml: Beractant Contains 25mg Of Phospholipids; 8 ml (200mg Phospholipids) Vial.
Pregnancy
Consult with Doctor Or Caution Advised
Stability
- Lung Surfactant
Contra Indications
- None Known
Precautions
- None Known
Lactation
- Consult with Doctor Or Caution Advised
Side Effects
- Gi Disturbance
- Irritability
- Restlessness And Jitteriness
- Tachycardia
- Hypertension
- See Literature.